Crossmark

Unveiling the capability of FDA-approved drugs targeting Zika virus E protein structural domains via molecular docking, dynamic simulation and in silico screening

Crossref DOI link: https://doi.org/10.1007/s13721-025-00629-8

Published Online: 2025-11-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mahnoor,

Mateen, Rana Muhammad

Javed, Mohsin

Ali, Muhammad

Parveen, Rukhsana

Ali, Syed Kashif

Asimov, Ahmed

Bahadur, Ali

Iqbal, Shahid https://orcid.org/0000-0003-3866-3216
Mahmood, Sajid

Alghamdi, Abeer Ahmed

Althobiti, Randa A.

Jafri, Ibrahim
Funding

Funding for this research was provided by:

Taif University (TU-DSPP-2024-205)
License Information

Text and Data Mining valid from 2025-11-04

Version of Record valid from 2025-11-04
More Information

Article History

Received: 31 May 2025

Revised: 2 October 2025

Accepted: 4 October 2025

First Online: 4 November 2025

Declarations

:

: There are no conflicts to declare.

: This article does not contain any study with human participants or animals, performed by any of the authors.

Document is current

Any future updates will be listed below